Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Insomnia Market Forecast Highlighting Growth From $5.51 Billion To $7.03 Billion
The insomnia market size has grown strongly in recent years. It will grow from $5.22 billion in 2025 to $5.52 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising prevalence of sleep disorders, increased stress and lifestyle changes, widespread use of benzodiazepines and sedatives, growing diagnosis rates of insomnia, expansion of sleep clinics and specialists.
The insomnia market size is expected to see strong growth in the next few years. It will grow to $7.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing adoption of digital therapeutics, growing demand for safer long-term insomnia treatments, rising geriatric population, increasing mental health awareness, expansion of online and retail pharmacy access. Major trends in the forecast period include growing adoption of non-pharmacological insomnia treatments, rising use of cognitive behavioral therapy for insomnia, increasing preference for personalized sleep management, expanding use of combination therapy approaches, growing awareness of chronic insomnia as a medical condition.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12120&type=smp
Insomnia Market Demand Drivers Creating New Revenue Opportunities
The increasing prevalence of chronic diseases is expected to propel the growth of insomnia market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Individuals suffering from chronic diseases, such as cardiovascular disorders, diabetes, and chronic pain conditions, often experience insomnia or other sleep-related issues as a comorbidity. This increased prevalence creates a demand for effective insomnia treatments and management strategies, driving the market for products and services designed to address sleep disorders. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of US adults representing about 194 million people reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the increasing prevalence of chronic diseases is driving the growth of the insomnia market.
Insomnia Market Segments: Where Are The Largest Growth Opportunities?
The insomnia market covered in this report is segmented –
1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy
2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy
2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements
Insomnia Market Trends Driving Strategic Industry Expansion
Major companies operating in the insomnia market are developing new products such as zaleplon-based insomnia drugs to gain a competitive edge in the market. Zaleplon is a non-benzodiazepine sedative-hypnotic medication used for the short-term treatment of insomnia. For instance, in April 2023, Bukwang Pharm Co Ltd., a South Korea-based pharmaceutical company, launched Zaledeep Cap., the first insomnia treatment in South Korea utilizing zaleplon as its main ingredient. Zaleplon, a non-benzodiazepine drug with FDA approval for treating insomnia, is known for its rapid onset of action, short half-life, and minimal impact on daily activities. With increasing insomnia cases in modern society, the launch of Zaledeep Cap. is expected to provide a new and effective treatment option, aiming to enhance sleep quality and overall well-being for individuals suffering from insomnia.
Insomnia Market Major Participants And Competitive Dynamics
Major companies operating in the insomnia market are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.
Access The Complete Insomnia Market Report:
https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report
Insomnia Market Largest Region By Revenue And Market Share
North America was the largest region in the insomnia market in 2025. The regions covered in the insomnia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model